Psychosocial Aspects of Oncology

1. Front Matter

   Pages I-VIII

   PDF

2. Historical Overview

   1. Front Matter

      Pages 1-1

      PDF

   2. Psychosocial Issues in Oncology: A Historical Perspective

      • Jimmie C. Holland, Robert Zittoun

      Pages 3-9

3. Patient Care Issues

   1. Front Matter

      Pages 11-11

      PDF

   2. Crisis and Coping — Learning to Live with Cancer

      • Christina Bolund

      Pages 13-25

   3. Patient Information and Participation

      • Robert Zittoun

      Pages 27-44

   4. Patient Information: Practical Guidelines

      • C. Hürny

      Pages 45-47

   5. Diagnosis and Management of Symptoms from a Psychological Perspective

      • Jimmie C. Holland

      Pages 49-57

   6. Employing Specialist Workers to Detect Psychological and Social Morbidity

      • Peter Maguire

      Pages 59-65

   7. Psychological and Psychiatric Interventions

      • Peter Maguire

      Pages 67-72

4. Psychosocial and Behavioural Factors in Cancer Risk and Survival

   1. Front Matter

      Pages 73-73

      PDF

   2. Psychosocial Risk Factors in Cancer

      • C. Hürny

      Pages 75-82

   3. Behavioural Factors in Cancer Risk and Survival

      • Darius Razavi, Jimmie C. Holland

      Pages 83-90

5. Methods of Assessment in Clinical Practice and Research

   1. Front Matter

      Pages 91-91

      PDF

   2. Screening for the Need of Psychosocial Intervention

      • Peter Maguire, Darius Razavi

      Pages 93-96

   3. Quality of Life Assessment in Cancer Clinical Trials

      • Neil K. Aaronson

      Pages 97-113

6. Future Directions for Training and Research

   1. Front Matter

      Pages 115-115

      PDF

   2. Informed Consent and Cancer Clinical Research

      • Neil K. Aaronson, Robert Zittoun

      Pages 117-120

   3. Suicide and Euthanasia

      • Christina Bolund

      Pages 121-122

   4. Unorthodox Cancer Treatments

      • Neil K. Aaronson, Jimmie C. Holland

      Pages 123-125

The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli­ nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the prinr.ir~-' ther::!PG~tic c0r'liuversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of on­ cology.

• Training
• assessment
• breast cancer
• cancer
• cancer treatment
• clinical trial
• crisis
• diagnosis
• intervention
• management
• morbidity
• oncology
• quality of life
• screening
• suicide

• Psychiatry Service, Memorial Solan-Kettering Cancer Center, New York, USA

  Jimmie C. Holland

• Service d’Hématologie, Hôtel-Dieu, Paris Cedex 04, France

  Robert Zittoun

Policies and ethics